Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-26

FDA Approved: LEVETIRACETAM — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic levetiracetam product from Bionpharma Inc., allowing its marketing in the United States. This represen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)